DEF 14AThe Ballot
BridgeBio Pharma, Inc. files DEF 14A
Filed Nov 8, 2021 · 4y ago · Accession 0001193125-21-323214
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- DEF 14A
- Filing date
- Nov 8, 2021
- Report date
- Dec 15, 2021
- Document
- d164684ddef14a.htm
- Size
- 1.1 MB